Cargando…

FBXO7 Y52C Polymorphism as a Potential Protective Factor in Parkinson's Disease

Mutations in the F-box only protein 7 gene (FBXO7), the substrate-specifying subunit of SCF E3 ubiquitin ligase complex, cause Parkinson's disease (PD)-15 (PARK15). To identify new variants, we sequenced FBXO7 cDNA in 80 Taiwanese early onset PD patients (age at onset ≤50) and only two known va...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Chiung-Mei, Chen, I-Cheng, Huang, Yi-Cheng, Juan, Hsueh-Fen, Chen, Ying-Lin, Chen, Yi-Chun, Lin, Chih-Hsin, Lee, Li-Ching, Lee, Chi-Mei, Lee-Chen, Guey-Jen, Lai, Yun-Ju, Wu, Yih-Ru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4100735/ https://www.ncbi.nlm.nih.gov/pubmed/25029497 http://dx.doi.org/10.1371/journal.pone.0101392

Ejemplares similares

Genetic Analysis of EGLN1 C127S Variant in Taiwanese Parkinson's Disease
por: Chiang, Han-Lin, et al.
Publicado: (2020)

Rare VPS35 A320V Variant in Taiwanese Parkinson’s Disease Indicates Disrupted CI-MPR Sorting and Impaired Mitochondrial Morphology
por: Wu, Yih-Ru, et al.
Publicado: (2020)

STK39, But Not BST1, HLA-DQB1, and SPPL2B Polymorphism, Is Associated With Han-Chinese Parkinson's Disease in Taiwan
por: Chang, Kuo-Hsuan, et al.
Publicado: (2015)

Pathomechanism Characterization and Potential Therapeutics Identification for Parkinson’s Disease Targeting Neuroinflammation
por: Chen, Chiung-Mei, et al.
Publicado: (2021)

Association between GRN rs5848 Polymorphism and Parkinson′s Disease in Taiwanese Population
por: Chang, Kuo-Hsuan, et al.
Publicado: (2013)

Investigating Therapeutic Effects of Indole Derivatives Targeting Inflammation and Oxidative Stress in Neurotoxin-Induced Cell and Mouse Models of Parkinson’s Disease
por: Chiu, Ya-Jen, et al.
Publicado: (2023)

Neuroprotection of Indole-Derivative Compound NC001-8 by the Regulation of the NRF2 Pathway in Parkinson's Disease Cell Models
por: Wei, Pei-Cih, et al.
Publicado: (2019)

Associations of Matrix Metalloproteinase-9 and Tissue Inhibitory Factor-1 Polymorphisms With Parkinson Disease in Taiwan
por: Chen, Yi-Chun, et al.
Publicado: (2016)

Genetic Variants of LRRK2 in Taiwanese Parkinson’s Disease
por: Wu, Yih-Ru, et al.
Publicado: (2013)

Formulated Chinese medicine Shaoyao Gancao Tang reduces NLRP1 and NLRP3 in Alzheimer’s disease cell and mouse models for neuroprotection and cognitive improvement
por: Chiu, Ya-Jen, et al.
Publicado: (2021)

Aqueous Extract of Paeonia lactiflora and Paeoniflorin as Aggregation Reducers Targeting Chaperones in Cell Models of Spinocerebellar Ataxia 3
por: Chang, Kuo-Hsuan, et al.
Publicado: (2013)

Fibroblast Growth Factor 20 Gene Polymorphism in Parkinson’s Disease in Asian Population: A Meta-Analysis
por: Chiang, Han-Lin, et al.
Publicado: (2021)

Coumarin-chalcone hybrid LM-021 and indole derivative NC009-1 targeting inflammation and oxidative stress to protect BE(2)-M17 cells against α-synuclein toxicity
por: Yang, Pei-Ning, et al.
Publicado: (2023)

Polymorphisms of Interleukin-6 and Interleukin-8 Are Not Associated with Parkinson’s Disease in Taiwan
por: Liu, Tsai-Wei, et al.
Publicado: (2021)

Lactulose and Melibiose Attenuate MPTP-Induced Parkinson’s Disease in Mice by Inhibition of Oxidative Stress, Reduction of Neuroinflammation and Up-Regulation of Autophagy
por: Lin, Chih-Hsin, et al.
Publicado: (2020)

Pathomechanism characterization and potential therapeutics identification for SCA3 targeting neuroinflammation
por: Chiu, Ya-Jen, et al.
Publicado: (2020)

Association between CSF1 and CSF1R Polymorphisms and Parkinson’s Disease in Taiwan
por: Chang, Kuo-Hsuan, et al.
Publicado: (2019)

Association of TNF-α gene with spontaneous deep intracerebral hemorrhage in the Taiwan population: a case control study
por: Chen, Yi-Chun, et al.
Publicado: (2010)

Shaoyao Gancao Tang (SG-Tang), a formulated Chinese medicine, reduces aggregation and exerts neuroprotection in spinocerebellar ataxia type 17 (SCA17) cell and mouse models
por: Chen, Chiung-Mei, et al.
Publicado: (2019)

Polymorphisms of ACMSD-TMEM163, MCCC1, and BCKDK-STX1B Are Not Associated with Parkinson's Disease in Taiwan
por: Chang, Kuo-Hsuan, et al.
Publicado: (2019)

Formulated Chinese Medicine Shaoyao Gancao Tang Reduces Tau Aggregation and Exerts Neuroprotection through Anti-Oxidation and Anti-Inflammation
por: Chen, I-Cheng, et al.
Publicado: (2018)

The aqueous extract of Glycyrrhiza inflata can upregulate unfolded protein response-mediated chaperones to reduce tau misfolding in cell models of Alzheimer’s disease
por: Chang, Kuo-Hsuan, et al.
Publicado: (2016)

Exploration of multi‐target effects of 3‐benzoyl‐5‐hydroxychromen‐2‐one in Alzheimer’s disease cell and mouse models
por: Lin, Te‐Hsien, et al.
Publicado: (2020)

Spinocerebellar ataxia type 8 larger triplet expansion alters histone modification and induces RNA foci
por: Chen, I-Cheng, et al.
Publicado: (2009)

LRRK2 A419V Is Not Associated with Parkinson's Disease in Different Chinese Populations
por: Wu, Yih Ru, et al.
Publicado: (2012)

New Synthetic 3-Benzoyl-5-Hydroxy-2H-Chromen-2-One (LM-031) Inhibits Polyglutamine Aggregation and Promotes Neurite Outgrowth through Enhancement of CREB, NRF2, and Reduction of AMPKα in SCA17 Cell Models
por: Chen, Chiung-Mei, et al.
Publicado: (2020)

Pueraria lobata and Daidzein Reduce Cytotoxicity by Enhancing Ubiquitin-Proteasome System Function in SCA3-iPSC-Derived Neurons
por: Chen, I-Cheng, et al.
Publicado: (2019)

Internal Ribosome Entry Segment Activity of ATXN8 Opposite Strand RNA
por: Chen, I-Cheng, et al.
Publicado: (2013)

Lactulose and Melibiose Inhibit α-Synuclein Aggregation and Up-Regulate Autophagy to Reduce Neuronal Vulnerability
por: Chen, Chiung Mei, et al.
Publicado: (2020)

Downregulation of Genes Involved in Metabolism and Oxidative Stress in the Peripheral Leukocytes of Huntington's Disease Patients
por: Chang, Kuo-Hsuan, et al.
Publicado: (2012)

Phosphorylated α-synuclein in diluted human serum as a biomarker for Parkinson's disease
por: Chen, Wei-Ru, et al.
Publicado: (2022)

Genetic Variations of GAK in Two Chinese Parkinson’s Disease Populations: A Case-Control Study
por: Tseng, Wei-En Johnny, et al.
Publicado: (2013)

Multi-Target Effects of Novel Synthetic Coumarin Derivatives Protecting Aβ-GFP SH-SY5Y Cells against Aβ Toxicity
por: Huang, Ching-Chia, et al.
Publicado: (2021)

Role of High Mobility Group Box 1 (HMGB1) in SCA17 Pathogenesis
por: Lee, Li-Ching, et al.
Publicado: (2014)

Using ΔK280 Tau(RD) Folding Reporter Cells to Screen TRKB Agonists as Alzheimer’s Disease Treatment Strategy
por: Weng, Zheng-Kui, et al.
Publicado: (2023)

A common genetic factor for Parkinson disease in ethnic Chinese population in Taiwan
por: Fung, Hon-Chung, et al.
Publicado: (2006)

Novel Synthetic Coumarin-Chalcone Derivative (E)-3-(3-(4-(Dimethylamino)Phenyl)Acryloyl)-4-Hydroxy-2H-Chromen-2-One Activates CREB-Mediated Neuroprotection in Aβ and Tau Cell Models of Alzheimer's Disease
por: Chiu, Ya-Jen, et al.
Publicado: (2021)

Increased Rab35 expression is a potential biomarker and implicated in the pathogenesis of Parkinson's disease
por: Chiu, Ching-Chi, et al.
Publicado: (2016)

Emerging role of FBXO22 in carcinogenesis
por: Cheng, Jiangting, et al.
Publicado: (2020)

Role of the CCAAT-Binding Protein NFY in SCA17 Pathogenesis
por: Lee, Li-Ching, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_olbagn26s296bmorpam8mr9bdh